Vivo Capital IX, LLC 13D/13G Filings for SINOVAC BIOTECH LTD (SVA)

Vivo Capital IX, LLC 13D and 13G filings for SINOVAC BIOTECH LTD:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-03-19
3:00 pm
Purchase
2025-03-17 13D SINOVAC BIOTECH LTD
SVA
Vivo Capital IX, LLC 4,539,456
6.300%
4,539,456increase
(New Position)
Filing